Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 176, Issue 4, Pages 539-552
Publisher
Wiley
Online
2016-12-18
DOI
10.1111/bjh.14461
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early-onset breast cancer patients in the South and Southeast of Brazil should be tested for the TP53 p.R337H mutation
- (2016) Kelvin C. Andrade et al. GENETICS AND MOLECULAR BIOLOGY
- Super-TransactivationTP53Variant in the Germline of a Family with Li-Fraumeni Syndrome
- (2016) Badr Id Said et al. HUMAN MUTATION
- Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study
- (2016) Anita Villani et al. LANCET ONCOLOGY
- Exploring genomic alteration in pediatric cancer using ProteinPaint
- (2016) Xin Zhou et al. NATURE GENETICS
- Somatic TP53 Mutations in the Era of Genome Sequencing
- (2016) Pierre Hainaut et al. Cold Spring Harbor Perspectives in Medicine
- Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels
- (2015) Charles G. Mullighan et al. BLOOD
- Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia
- (2015) Jane E. Churpek et al. CANCER
- Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers
- (2015) Gaëlle Bougeard et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevalence and Functional Consequence ofTP53Mutations in Pediatric Adrenocortical Carcinoma: A Children's Oncology Group Study
- (2015) Jonathan D. Wasserman et al. JOURNAL OF CLINICAL ONCOLOGY
- Germline TP53 Variants and Susceptibility to Osteosarcoma
- (2015) Lisa Mirabello et al. JNCI-Journal of the National Cancer Institute
- Germline Mutations in Predisposition Genes in Pediatric Cancer
- (2015) Jinghui Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic landscape of paediatric adrenocortical tumours
- (2015) Emilia M. Pinto et al. Nature Communications
- Germline TP53 Variants and Susceptibility to Osteosarcoma
- (2015) Lisa Mirabello et al. JNCI-Journal of the National Cancer Institute
- Occurrence of Neuroblastoma among TP53 p.R337H Carriers
- (2015) Ana Luiza Seidinger et al. PLoS One
- GermlineTP53Mutations and the Changing Landscape of Li-Fraumeni Syndrome
- (2014) Junne Kamihara et al. HUMAN MUTATION
- Li-Fraumeni syndrome: cancer risk assessment and clinical management
- (2014) Kate A. McBride et al. Nature Reviews Clinical Oncology
- Anaplastic rhabdomyosarcoma inTP53germline mutation carriers
- (2013) Simone Hettmer et al. CANCER
- Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil
- (2013) Juliana Giacomazzi et al. CANCER
- The MDM2 285G–309G haplotype is associated with an earlier age of tumour onset in patients with Li-Fraumeni syndrome
- (2013) Mariette Renaux-Petel et al. Familial Cancer
- Subgroup-Specific Prognostic Implications ofTP53Mutation in Medulloblastoma
- (2013) Nataliya Zhukova et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor Protein p53 (TP53) Testing and Li-Fraumeni Syndrome
- (2013) April D. Sorrell et al. Molecular Diagnosis & Therapy
- The genomic landscape of hypodiploid acute lymphoblastic leukemia
- (2013) Linda Holmfeldt et al. NATURE GENETICS
- The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans
- (2012) V. Pant et al. BLOOD
- Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort
- (2012) Serena Masciari et al. BREAST CANCER RESEARCH AND TREATMENT
- Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations
- (2012) Tobias Rausch et al. CELL
- Routine TP53 testing for breast cancer under age 30: ready for prime time?
- (2012) Jeanna M. McCuaig et al. Familial Cancer
- Germline mutations in the DNA damage response genesBRCA1,BRCA2,BARD1andTP53in patients with therapy related myeloid neoplasms
- (2012) Eduard Schulz et al. JOURNAL OF MEDICAL GENETICS
- Identification ofTP53as an acute lymphocytic leukemia susceptibility gene through exome sequencing
- (2012) Bradford C. Powell et al. PEDIATRIC BLOOD & CANCER
- The p53 network: cellular and systemic DNA damage responses in aging and cancer
- (2012) H. Christian Reinhardt et al. TRENDS IN GENETICS
- Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium
- (2012) Phuong L. Mai et al. Cancer Genetics
- Sarcomas in TP53 germline mutation carriers
- (2011) Simona Ognjanovic et al. CANCER
- Early onset HER2-positive breast cancer is associated with germlineTP53mutations
- (2011) Amal Melhem-Bertrandt et al. CANCER
- Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study
- (2011) Anita Villani et al. LANCET ONCOLOGY
- Molecular epidemiology of adrenocortical tumors in southern Brazil
- (2011) Gislaine Custódio et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Population-Based Estimate of the Contribution ofTP53Mutations to Subgroups of Early-Onset Breast Cancer: Australian Breast Cancer Family Study: Table 1.
- (2010) Judy Mouchawar et al. CANCER RESEARCH
- Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits
- (2010) C. R. M. Lammens et al. Familial Cancer
- The p53 tumor suppressor protein regulates hematopoietic stem cell fate
- (2010) Takashi Asai et al. JOURNAL OF CELLULAR PHYSIOLOGY
- TP53 Alterations Determine Clinical Subgroups and Survival of Patients With Choroid Plexus Tumors
- (2010) Uri Tabori et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic Testing in Li-Fraumeni Syndrome: Uptake and Psychosocial Consequences
- (2010) Chantal R.M. Lammens et al. JOURNAL OF CLINICAL ONCOLOGY
- TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes
- (2010) M. W. G. Ruijs et al. JOURNAL OF MEDICAL GENETICS
- Radio-induced malignancies after breast cancer post-operative radiotherapy in patients with Li- Fraumeni syndrome
- (2010) Steve Heymann et al. Radiation Oncology
- Radiotherapy in the Treatment of Hereditary Breast Cancer
- (2010) Lori J. Pierce et al. SEMINARS IN RADIATION ONCOLOGY
- Transcriptional Regulation by P53
- (2010) R. Beckerman et al. Cold Spring Harbor Perspectives in Biology
- Blinded by the Light: The Growing Complexity of p53
- (2009) Karen H. Vousden et al. CELL
- p53 Regulates Hematopoietic Stem Cell Quiescence
- (2009) Yan Liu et al. Cell Stem Cell
- Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome
- (2009) Edenir I Palmero et al. CURRENT OPINION IN ONCOLOGY
- 2009 Version of the Chompret Criteria for Li Fraumeni Syndrome
- (2009) Julie Tinat et al. JOURNAL OF CLINICAL ONCOLOGY
- Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families Withp53Germline Mutations
- (2009) Kelly D. Gonzalez et al. JOURNAL OF CLINICAL ONCOLOGY
- TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosis
- (2009) V Marcel et al. JOURNAL OF MEDICAL GENETICS
- High frequency of de novo mutations in Li-Fraumeni syndrome
- (2009) K D Gonzalez et al. JOURNAL OF MEDICAL GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started